Company overview
DEBRA organizations, including DEBRA of America and DEBRA Research, support pharmaceutical R&D for Epidermolysis Bullosa (EB) therapies through research funding, infrastructure projects like patient registries and biobanks, and partnerships with industry. They facilitate clinical trial networks, preclinical models, and collaborations with pharma companies such as LEO Pharma to advance EB treatments. These non-profits connect developers with patient communities and global experts to accelerate therapy development.
Programs, Advocacy & Research is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include debra research, eb therapy development, patient registries, clinical trial networks, pharma partnerships.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.debra.org/
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- debra research, eb therapy development, patient registries, clinical trial networks, pharma partnerships
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What research infrastructure does DEBRA provide for EB drug development?
- DEBRA Research builds patient registries, biobanks, disease models, and clinical trial networks to support preclinical and clinical phases of EB therapy development.
- Does DEBRA partner with pharmaceutical companies for EB treatments?
- Yes, DEBRA Research collaborates with pharma like LEO Pharma on strategic partnerships to advance EB research and clinical applications.
- What are DEBRA's geographic capabilities for EB research support?
- DEBRA operates worldwide through DEBRA International's network of nearly 50 national groups, with DEBRA Research focusing on global collaborations across academia, industry, and regulators.
Related editorial coverage
- BioMed Israel: Daily Highlights and Key Takeaways
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
